325 related articles for article (PubMed ID: 31449470)
1. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
Wang CC; Chou HH; Yang LY; Lin H; Liou WS; Tseng CW; Liu FY; Liou JD; Huang KG; Huang HJ; Huang EY; Chen CH; Chang TC; Chang CJ; Hong JH; Lai CH
Gynecol Oncol; 2015 Jun; 137(3):462-7. PubMed ID: 25827291
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
[TBL] [Abstract][Full Text] [Related]
4. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
Nunes de Arruda F; da Costa S; Bonadio R; Dornellas A; Pereira D; de Bock GH; Del Pilar Estevez Diz M
Int J Gynecol Cancer; 2020 Jun; 30(6):749-756. PubMed ID: 32321767
[TBL] [Abstract][Full Text] [Related]
5. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
Dueñas-González A; Zarbá JJ; Patel F; Alcedo JC; Beslija S; Casanova L; Pattaranutaporn P; Hameed S; Blair JM; Barraclough H; Orlando M
J Clin Oncol; 2011 May; 29(13):1678-85. PubMed ID: 21444871
[TBL] [Abstract][Full Text] [Related]
6. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies.
Duenas-Gonzalez A; Lopez-Graniel C; Gonzalez-Enciso A; Mohar A; Rivera L; Mota A; Guadarrama R; Chanona G; De La Garza J
Ann Oncol; 2002 Aug; 13(8):1212-9. PubMed ID: 12181244
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
de Azevedo CRAS; Thuler LCS; de Mello MJG; de Oliveira Lima JT; da Fonte ALF; Fontão DFS; Carneiro VCG; Chang TMC; Ferreira CG
Gynecol Oncol; 2017 Sep; 146(3):560-565. PubMed ID: 28709705
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes of neoadjuvant chemotherapy-related strategies compared with concurrent chemoradiotherapy for locally advanced cervical cancer: a meta-analysis of randomized controlled trials.
Wang B; Tan Y; Yang X; Man X
Arch Gynecol Obstet; 2021 Aug; 304(2):485-493. PubMed ID: 33389099
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
Li J; Li Y; Wang H; Shen L; Wang Q; Shao S; Shen Y; Xu H; Liu H; Cai R; Feng W
BMC Cancer; 2023 Jan; 23(1):51. PubMed ID: 36641433
[TBL] [Abstract][Full Text] [Related]
10. Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2
Zhong WZ; Chen KN; Chen C; Gu CD; Wang J; Yang XN; Mao WM; Wang Q; Qiao GB; Cheng Y; Xu L; Wang CL; Chen MW; Kang X; Yan W; Yan HH; Liao RQ; Yang JJ; Zhang XC; Zhou Q; Wu YL
J Clin Oncol; 2019 Sep; 37(25):2235-2245. PubMed ID: 31194613
[TBL] [Abstract][Full Text] [Related]
11. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
[TBL] [Abstract][Full Text] [Related]
13. A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma.
Reni M; Zanon S; Balzano G; Passoni P; Pircher C; Chiaravalli M; Fugazza C; Ceraulo D; Nicoletti R; Arcidiacono PG; Macchini M; Peretti U; Castoldi R; Doglioni C; Falconi M; Partelli S; Gianni L
Eur J Cancer; 2018 Oct; 102():95-102. PubMed ID: 30149366
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.
Phippen NT; Leath CA; Chino JP; Jewell EL; Havrilesky LJ; Barnett JC
Gynecol Oncol; 2012 Nov; 127(2):267-72. PubMed ID: 22892361
[TBL] [Abstract][Full Text] [Related]
15. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
Dueñas-González A; Cetina-Perez L; Lopez-Graniel C; Gonzalez-Enciso A; Gómez-Gonzalez E; Rivera-Rubi L; Montalvo-Esquivel G; Muñoz-Gonzalez D; Robles-Flores J; Vazquez-Govea E; de La Garza J; Mohar A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):817-23. PubMed ID: 15708261
[TBL] [Abstract][Full Text] [Related]
16. Is the progression free survival advantage of concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in patients with advanced cervical cancer worth the additional cost? A cost-effectiveness analysis.
Smith B; Cohn DE; Clements A; Tierney BJ; Straughn JM
Gynecol Oncol; 2013 Sep; 130(3):416-20. PubMed ID: 23718933
[TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
[TBL] [Abstract][Full Text] [Related]
18. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
Zarbá JJ; Jaremtchuk AV; Gonzalez Jazey P; Keropian M; Castagnino R; Mina C; Arroyo G;
Ann Oncol; 2003 Aug; 14(8):1285-90. PubMed ID: 12881394
[TBL] [Abstract][Full Text] [Related]
19. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Gakis G; Morgan TM; Daneshmand S; Keegan KA; Todenhöfer T; Mischinger J; Schubert T; Zaid HB; Hrbacek J; Ali-El-Dein B; Clayman RH; Galland S; Olugbade K; Rink M; Fritsche HM; Burger M; Chang SS; Babjuk M; Thalmann GN; Stenzl A; Efstathiou JA
Ann Oncol; 2015 Aug; 26(8):1754-9. PubMed ID: 25969370
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.
Hui EP; Ma BB; Leung SF; King AD; Mo F; Kam MK; Yu BK; Chiu SK; Kwan WH; Ho R; Chan I; Ahuja AT; Zee BC; Chan AT
J Clin Oncol; 2009 Jan; 27(2):242-9. PubMed ID: 19064973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
